Micah Mitchell Sells 90,231 Shares of Myomo (NYSEAMERICAN:MYO) Stock

Myomo, Inc. (NYSEAMERICAN:MYO) insider Micah Mitchell sold 90,231 shares of the business’s stock in a transaction that occurred on Wednesday, May 14th. The stock was sold at an average price of $0.86, for a total transaction of $77,598.66. Following the sale, the insider directly owned 109,478 shares of the company’s stock, valued at approximately $94,151.08. This trade represents a 45.18% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Myomo Trading Up 2.5%

Shares of MYO traded up $0.02 on Friday, reaching $0.91. 505,712 shares of the company’s stock were exchanged, compared to its average volume of 419,217. The company has a current ratio of 2.73, a quick ratio of 2.93 and a debt-to-equity ratio of 1.21. The stock has a market capitalization of $35.17 million, a P/E ratio of -2.53 and a beta of 1.39. The business has a 50 day moving average price of $0.76 and a two-hundred day moving average price of $0.85. Myomo, Inc. has a 12 month low of $0.61 and a 12 month high of $3.69.

Institutional Investors Weigh In On Myomo

Several large investors have recently bought and sold shares of MYO. Cubist Systematic Strategies LLC increased its stake in Myomo by 157.4% in the first quarter. Cubist Systematic Strategies LLC now owns 49,101 shares of the company’s stock valued at $236,000 after purchasing an additional 30,028 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in Myomo in the first quarter valued at approximately $75,000. Jane Street Group LLC increased its stake in Myomo by 84.2% in the first quarter. Jane Street Group LLC now owns 162,658 shares of the company’s stock valued at $782,000 after purchasing an additional 74,338 shares in the last quarter. Acadian Asset Management LLC bought a new stake in Myomo in the first quarter valued at approximately $114,000. Finally, Geode Capital Management LLC increased its stake in Myomo by 160.8% in the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock valued at $1,446,000 after purchasing an additional 412,631 shares in the last quarter. Institutional investors own 44.99% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Craig Hallum reissued a “buy” rating on shares of Myomo in a research note on Tuesday, March 10th. Four equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $7.67.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.